Concert Pharmaceuticals I... (CNCE)
NASDAQ: CNCE
· Real-Time Price · USD
8.37
0.00 (0.00%)
At close: Mar 03, 2023, 10:00 PM
Company Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases.
The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition.
It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals.
The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Concert Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Feb 13, 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 64 |
| CEO | Roger D. Tung |
Contact Details
Address: 65 Hayden Avenue Lexington, Massachusetts United States | |
| Website | https://www.concertpharma.com |
Stock Details
| Ticker Symbol | CNCE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001367920 |
| CUSIP Number | 206022105 |
| ISIN Number | US2060221056 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Roger D. Tung Ph.D. | Co-Founder, Chief Executive Officer, Pres & Executive Director |
| Jeffrey A. Munsie | Chief Legal Officer & Corporation Sec. |
| Marc A. Becker | Chief Financial Officer |
| Nancy Stuart | Chief Operating Officer |
| Christine Boisclair | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Dr. James V. Cassella Ph.D. | Chief Devel. Officer |
| Dr. Nabil Uddin Pharm.D. | Vice President of Corporation Devel. |
| Justine E. Koenigsberg | Senior Vice President of Corporation Communications & Investor Relations |
| Kimberly Mack | Vice President of HR |
| Richard H. Aldrich M.B.A., Mba | Co-Founder & Independent Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 16, 2023 | 15-12G | Filing |
| Mar 06, 2023 | 25-NSE | Filing |
| Mar 06, 2023 | S-8 POS | Filing |
| Mar 06, 2023 | S-8 POS | Filing |
| Mar 06, 2023 | S-8 POS | Filing |
| Mar 06, 2023 | S-8 POS | Filing |
| Mar 06, 2023 | 4 | Filing |
| Mar 06, 2023 | 4 | Filing |
| Mar 06, 2023 | 4 | Filing |
| Mar 06, 2023 | 4 | Filing |